iSpecimen Inc Market Cap ($1.99 Million)
Market Cap & Net Worth: iSpecimen Inc (ISPC)
iSpecimen Inc market cap. iSpecimen Inc (NASDAQ:ISPC) has a market capitalization of $1.99 Million ($1.99 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30043 globally and #6131 in its home market, demonstrating a -5.97% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying iSpecimen Inc's stock price $0.79 by its total outstanding shares 2518590 (2.52 Million). Also see iSpecimen Inc cash flow conversion for how efficiently the company converts equity into cash flow.
iSpecimen Inc Market Cap History (2021–2026)
iSpecimen Inc market cap history from 2021 to 2026. Data shows change from $393.40 Million to $1.99 Million (-61.93% CAGR). Check iSpecimen Inc stock quote for real-time trading data and today's change.
Index Memberships
iSpecimen Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #872 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2781 of 3165 |
Weight: iSpecimen Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
iSpecimen Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how iSpecimen Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ISPC shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.34x
iSpecimen Inc's market cap is 0.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $393.40 Million | $11.14 Million | -$8.96 Million | 35.33x | N/A |
| 2022 | $69.26 Million | $10.40 Million | -$10.25 Million | 6.66x | N/A |
| 2023 | $25.24 Million | $9.93 Million | -$11.10 Million | 2.54x | N/A |
| 2024 | $6.69 Million | $9.29 Million | -$12.50 Million | 0.72x | N/A |
| 2025 | $655.09K | $1.93 Million | -$10.49 Million | 0.34x | N/A |
Competitor Companies of ISPC by Market Capitalization
Companies near iSpecimen Inc in the global market cap rankings as of November 4, 2026. Also see ISPC current and non-current assets for a full breakdown of the balance sheet.
Key companies related to iSpecimen Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #142 globally with a market cap of $162.54 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #479 globally with a market cap of $56.02 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #546 globally with a market cap of $48.96 Billion USD ( CN¥334.59 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $698.34 |
| #142 | Danaher Corporation | NYSE:DHR | $162.54 Billion | $230.11 |
| #479 | Natera Inc | NASDAQ:NTRA | $56.02 Billion | $388.63 |
| #546 | WuXi AppTec Co Ltd | SHG:603259 | $48.96 Billion | CN¥135.28 |
Market Capitalization of iSpecimen Inc (2021–2026)
Market capitalization of iSpecimen Inc from 2021 to today. Between 2021 and today, iSpecimen Inc's market cap moved from $393.40 Million to $ 1.99 Million, with a yearly change of -61.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.99 Million | +203.61% |
| 2025 | $655.09K | -90.20% |
| 2024 | $6.69 Million | -73.50% |
| 2023 | $25.24 Million | -63.56% |
| 2022 | $69.26 Million | -82.39% |
| 2021 | $393.40 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of iSpecimen Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.99 Million USD |
| MoneyControl | $1.99 Million USD |
| MarketWatch | $1.99 Million USD |
| marketcap.company | $1.99 Million USD |
| Reuters | $1.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About iSpecimen Inc
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have ac… Read more